Search

A white paper from Canada and the United States focuses on collaboration between the two countries on their commitment to deal with the overdose crisis. "Substance Use and Harms During COVID‐19 and Approaches to Federal Surveillance and Response," issued Sept. 27, states that the increase in "substance use harms and deaths" during COVID‐19 is partly due to a decrease in access to services. The white paper itself focuses on the restrictions to methadone access in the United States and says little about the Canadian rules, but they are much more lenient. [ABSTRACT FROM AUTHOR]